Skip to main content Accessibility help
×
Home

The seroprevalance of Crimean-Congo haemorrhagic fever in people living in the same environment with Crimean-Congo haemorrhagic fever patients in an endemic region in Turkey

  • I. KOKSAL (a1), G. YILMAZ (a1), F. AKSOY (a1), S. ERENSOY (a1) and H. AYDIN (a1)...

Summary

Crimean-Congo haemorrhagic fever (CCHF) is endemic in Turkey, and since 2004 many cases have been reported from different regions of Turkey. There are limited data about the seroprevalence of the disease in household members of patients or persons sharing the same environment. We evaluated seroprevalence of CCHF in the immediate neighbourhood and in household members of patients living in the same environment as confirmed cases of CCHF in an endemic area of Turkey. A total of 625 healthy subjects [mean (s.d.) age: 42·3 (18·4) years, 58·7% females] without a past history of CCHF infection included in this case-control, retrospective study were evaluated in terms of sociodemographic characteristics, risk factors for CCHF via a study questionnaire, while serum analysis for CCHF virus (CCHFV) IgG antibodies was performed by ELISA. Anti-CCHFV IgG antibodies were positive in 85 (13·6%) participants. None of the seropositive individuals had a history of symptomatic infection. Regression analysis revealed that animal husbandry [odds ratio (OR) 1·84, 95% confidence interval (CI) 1·09–3·11], contact with animals (OR 2·31, 95% CI 1·08–5·10), contact with ticks (OR 3·45, 95% CI 1·87–6·46), removing ticks from animals by hand (OR 2·48, 95% CI 1·48–4·18) and living in a rural area (OR 4·05, 95% CI 1·65–10·56) were associated with increased odds of having IgG seropositivity, while being a household member of a patient with prior CCHF infection had no influence on seropositivity rates. This result also supports the idea that CCHF is not transmitted person-to-person by the airborne route.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      The seroprevalance of Crimean-Congo haemorrhagic fever in people living in the same environment with Crimean-Congo haemorrhagic fever patients in an endemic region in Turkey
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      The seroprevalance of Crimean-Congo haemorrhagic fever in people living in the same environment with Crimean-Congo haemorrhagic fever patients in an endemic region in Turkey
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      The seroprevalance of Crimean-Congo haemorrhagic fever in people living in the same environment with Crimean-Congo haemorrhagic fever patients in an endemic region in Turkey
      Available formats
      ×

Copyright

Corresponding author

* Author for correspondence: Professor I. Koksal, Karadeniz Technical University Medical Faculty, Infectious Diseases and Clinical Microbiology Department, Trabzon, Turkey. (Email: iftihar@yahoo.com)

References

Hide All
1. Whitehouse, CA. Crimean-Congo haemorrhagic fever. Antiviral Research 2004; 64: 145160.
2. Ergonul, O. Crimean-Congo haemorrhagic fever. Lancet Infectious Diseases 2006; 6: 203214.
3. Saijo, M, Morikawa, S, Kurane, I. Recent progress in the treatment for Crimean-Congo haemorrhagic fever and future perspectives. Future Virology 2010; 5: 801809.
4. Sidira, P, et al. Seroepidemiological study of Crimean-Congo haemorrhagic fever in Greece, 2009–2010. Clinical Microbiology and Infection 2012; 18: E1619.
5. Vorou, RM, Papavassiliou, VG, Tsiodras, S. Emerging zoonoses and vector-borne infections affecting humans in Europe. Epidemiology and Infection 2007; 135: 12311247.
6. Karti, SS, et al. Crimean-Congo haemorrhagic fever in Turkey. Emerging Infectious Diseases 2004; 19: 13791384.
7. Gunaydin, NS, et al. Crimean-Congo haemorrhagic fever cases in the eastern Black Sea Region of Turkey: demographic, geographic, climatic, and clinical characteristics. Turkish Journal of Medical Sciences 2010; 40: 829834.
8. Yilmaz, GR, et al. The epidemiology of Crimean-Congo haemorrhagic fever in Turkey, 2002–2007. International Journal of Infectious Diseases 2009; 13: 380386.
9. Chinikar, S, et al. Crimean-Congo haemorrhagic fever in Iran and neighboring countries. Journal of Clinical Virology 2010; 47: 110114.
10. Ergonul, O. Crimean-Congo haemorrhagic fever virus: new outbreaks, new discoveries. Current Opinion in Virology 2012; 2: 215220.
11. Gergova, I, Kunchev, M, Kamarinchev, B. Crimean-Congo haemorrhagic fever virustick survey in endemic areas in Bulgaria. Journal of Medical Virology 2012; 84: 608614.
12. Bodur, H, et al. Subclinical infections with Crimean-Congo haemorrhagic fever virus, Turkey. Emerging Infectious Diseases 2012; 18: 640642.
13. Izadi, S, et al. Crimean-Congo haemorrhagic fever in Sistan and Baluchestan Province of Iran, a case-control study on epidemiological characteristics. International Journal of Infectious Diseases 2004; 8: 299306.
14. Humolli, I, et al. Epidemiological, serological and herd immunity of Crimean-Congo haemorrhagic fever in Kosovo. Medical Archives 2010; 64: 9193.
15. Williams, RJ, et al. Crimean-congo haemorrhagic fever: a seroepidemiological and tick survey in the Sultanate of Oman. Tropical Medicine and International Health 2000; 5: 99106.
16. Ministry of Health, Turkey. Reports of the Communicable Diseases Department [in Turkish]. Ankara (Turkey): Ministry of Health, 2007.
17. Mathiot, CC, et al. Antibodies to haemorrhagic fever viruses in Madagascar populations. Transactions of the Royal Society Tropical Medicine and Hygiene 1989; 83: 407409.
18. Serter, D. Present status of arbovirus sero-epidemiology in the Aegean region of Turkey. In: Vesenjak-Hirjan, J, Porterfield, JS, Arslanagic, E, eds. Arboviruses in the Mediterranean Countries. Stuttgart: Gustav Fischer Verlag, 1980, pp. 155163.
19. Ergonul, O, et al. Zoonotic infections among veterinarians in Turkey: Crimean-Congo haemorrhagic fever and beyond. International Journal of Infectious Diseases 2006; 10: 465469.
20. Ergonul, O, et al. The lack of Crimean-Congo haemorrhagic fever virus antibodies in healthcare workers in an endemic region. International Journal of Infectious Diseases 2007; 11: 4851.
21. Gunes, T, et al. Crimean-Congo haemorrhagic fever virus in high-risk population, Turkey. Emerging Infectious Diseases 2009; 15: 461464.
22. Ertugrul, B, et al. The seroprevalence of Crimean-Congo haemorrhagic fever among inhabitants living in the endemic regions of Western Anatolia. Scandinavian Journal of Infectious Diseases 2012; 44: 276281.
23. Vatansever, Z, et al. Crimean-Congo haemorrhagic fever in Turkey. In: Ergonul, O, Whitehouse, CA, eds. Crimean-Congo Haemorrhagic Fever: A Global Perspective. Amsterdam: Springer, 2007, pp. 5974.
24. Koksal, I, et al. The efficacy of ribavirin in the treatment of Crimean-Congo haemorrhagic fever in Eastern Black Sea region in Turkey. Journal of Clinical Virology 2010; 47: 6568.
25. Ozkurt, Z, et al. Crimean-Congo haemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy. Journal of Infection 2006; 52: 207215.
26. Ergonul, O, et al. The characteristics of Crimean-Congo haemorrhagic fever in a recent outbreak in Turkey and the impact of oral ribavirin therapy. Clinical Infectious Diseases 2004; 39: 284288.
27. Tarantola, A, Ergonul, E, Tattevin, P. Estimates and prevention of Crimean Congo haemorrhagic fever risks for health-care workers. In: Ergonul, O, Whithouse, CA, eds. Crimean-Congo Haemorrhagic Fever: A Global Perspective. Amsterdam: Springer, 2007, pp. 281294.
28. Kirdar, S, Ertugrul, MB. Crimean-Congo haemorrhagic fever [in Turkish]. Journal of Adnan Menderes Medical Faculty 2009; 10: 4552.
29. Cevik, MA, et al. Viral load as a predictor of outcome in Crimean-Congo haemorrhagic fever. Clinical Infectious Diseases 2007; 45: 96100.
30. Saksida, A, et al. Interacting roles of immune mechanisms and viral load in the pathogenesis of Crimean-Congo haemorrhagic fever. Clinical and Vaccine Immunology 2010; 17: 10861093.
31. Cevik, MA, et al. Clinical and laboratory features of Crimean-Congo haemorrhagic fever: predictors of fatality. International Journal of Infectious Diseases 2008; 12: 374379.
32. Vorou, R, Pierroutsakos, IN, Maltezou, HC. Crimean-Congo haemorrhagic fever. Current Opinion in Infectious Diseases 2007; 20: 495500.

Keywords

Related content

Powered by UNSILO

The seroprevalance of Crimean-Congo haemorrhagic fever in people living in the same environment with Crimean-Congo haemorrhagic fever patients in an endemic region in Turkey

  • I. KOKSAL (a1), G. YILMAZ (a1), F. AKSOY (a1), S. ERENSOY (a1) and H. AYDIN (a1)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.